Prospective, observational, non-interventional, multicenter study to investigate treatment outcomes and patient satisfaction of Enstilum® foam (calcipotriol/betamethasone aerosol foam) as topical treatment of adult patients with psoriasis under the routine practice in Korea

Study identification

• EU PAS number:
  EUPAS38883
• Study ID:
  45566
• Official title and acronym:
  Prospective, observational, non-interventional, multicenter study to investigate treatment outcomes and patient satisfaction of Enstilum® foam (calcipotriol/betamethasone aerosol foam) as topical treatment of adult patients with psoriasis under the routine practice in Korea
• DARWIN EU® study:
  No
• Study countries:
  Korea, Republic of
• Study description:
  No information provided.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Seoul National University Bundang Hospital

Study timelines

Date when funding contract was signed

Planned:12/05/2020

Actual:12/05/2020

Study start date

Planned:28/05/2020

Actual:28/05/2020

Date of final study report

Planned:10/02/2022

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

LEO Pharma Korea

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable